AUSTRALIAN-LISTED medicine adherence and management tech specialist company MedAdvisor has announced the appointment of Dr David Chatterton as chief technology officer "to lead the development and enhancement of the platform as the Company enters its next phase of growth."
The announcement emphasised that Josh Swinnerton who covered that role previously would continue in the role of founder and chief product officer "working closely with the development team and helping to drive the Company's growth initiatives."
Chatterton brings extensive experience leading global software development operations with almost two decades working across software and hardware development projects implementing and growing multiple technology platforms both domestically and overseas.
MedAdvisor ceo Robert Read said, "Dr Chatterton's appointment is a reflection of the high calibre of talent that MedAdvisor has been able to attract to the business due to its innovative technology platform and global opportunity to help people feel better."
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 17
